These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 24043966)

  • 21. Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes.
    Song KD; Lee MW; Rhim H; Kang TW; Cha DI; Sinn DH; Lim HK
    Radiology; 2018 Sep; 288(3):878-886. PubMed ID: 29916771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computed tomography-guided radiofrequency ablation combined with transarterial embolization assisted by a three-dimensional visualization ablation planning system for hepatocellular carcinoma in challenging locations: a preliminary study.
    Huang ZM; Zuo MX; Gu YK; Gu HF; Lai CX; Zhang TQ; Wang XC; An C; Huang JH
    Abdom Radiol (NY); 2020 Apr; 45(4):1181-1192. PubMed ID: 32006072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initial radiofrequency ablation failure for hepatocellular carcinoma: repeated radiofrequency ablation versus transarterial chemoembolisation.
    Kim SS; Kang TW; Kim M; Lee MW; Cho SK; Paik YH; Kim MJ
    Clin Radiol; 2018 Feb; 73(2):216.e1-216.e8. PubMed ID: 28859852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transarterial chemoembolization plus multi-imaging-guided radiofrequency ablation for elimination of hepatocellular carcinoma nodules measuring 3.1 to 5.0 cm: a single-center study.
    Haochen W; Jian W; Li S; Tianshi L; Xiaoqiang T; Yinghua Z
    J Int Med Res; 2018 Jul; 46(7):2650-2657. PubMed ID: 29683022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of ultrasound-guided radiofrequency ablation in incompletely treated hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Chang NK; Shin SS; Kim JW; Kim HJ; Jeong YY; Heo SH; Kim JK; Kang HK
    Korean J Radiol; 2012; 13 Suppl 1(Suppl 1):S104-11. PubMed ID: 22563280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and Efficacy of Transarterial Chemoembolization Combined with CT-Guided Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to the Hepatic Hilum within Milan Criteria.
    Guo Y; Zhang Y; Huang J; Chen X; Huang W; Shan H; Zhu K
    J Vasc Interv Radiol; 2016 Apr; 27(4):487-95. PubMed ID: 26922006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival.
    Lee MW; Kang D; Lim HK; Cho J; Sinn DH; Kang TW; Song KD; Rhim H; Cha DI; Lu DSK
    Eur Radiol; 2020 Apr; 30(4):2391-2400. PubMed ID: 31900708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma.
    Ahn SJ; Lee JM; Lee DH; Lee SM; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
    J Hepatol; 2017 Feb; 66(2):347-354. PubMed ID: 27650284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients.
    Ippolito D; Fior D; Bonaffini PA; Capraro C; Leni D; Corso R; Sironi S
    Eur J Radiol; 2014 Sep; 83(9):1665-71. PubMed ID: 24962900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical utility of radiofrequency ablation following transarterial injection of miriplatin-iodized oil suspension in small hepatocellular carcinoma.
    Nakajima K; Yamanaka T; Nakatsuka A; Haruyuki T; Fujimori M; Sugino Y; Matsushita N; Sakuma H; Isaji S; Takei Y; Yamakado K
    Jpn J Radiol; 2016 Sep; 34(9):640-6. PubMed ID: 27455985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Radiofrequency Ablation and Transarterial Chemoembolization for Hepatocellular Carcinoma in the Caudate Lobe.
    Lee BC; Liu KL; Wu CH; Huang KW; Ho CM; Hu RH; Ho MC; Wu YM; Lee PH; Liang PC
    Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1699-1707. PubMed ID: 29946941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local recurrence of hepatocellular carcinoma after segmental transarterial chemoembolization: risk estimates based on multiple prognostic factors.
    Park SH; Cho YK; Ahn YS; Park YO; Kim JK; Chung JW
    Korean J Radiol; 2007; 8(2):111-9. PubMed ID: 17420628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Microwave and Radiofrequency Ablation for the Treatment of Small- and Medium-Sized Hepatocellular Carcinomas in a Prospective Randomized Trial.
    Vogl TJ; Martin SS; Gruber-Rouh T; Booz C; Koch V; Nour-Eldin NA; Hussainy Said MN
    Rofo; 2024 May; 196(5):482-490. PubMed ID: 38065541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].
    Guo YJ; Huang WS; Zhou B; Chen JW; Cai MY; Qian JS; Huang MS; Shan H; Zhu KS
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2627-30. PubMed ID: 24360041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spectral CT-Based Iodized Oil Quantification to Predict Tumor Response Following Chemoembolization of Hepatocellular Carcinoma.
    Choi WS; Chang W; Lee M; Hur S; Kim HC; Jae HJ; Chung JW; Choi JW
    J Vasc Interv Radiol; 2021 Jan; 32(1):16-22. PubMed ID: 33162309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous radiofrequency ablation for early hepatocellular carcinoma: risk factors for survival.
    Kikuchi L; Menezes M; Chagas AL; Tani CM; Alencar RS; Diniz MA; Alves VA; D'Albuquerque LA; Carrilho FJ
    World J Gastroenterol; 2014 Feb; 20(6):1585-93. PubMed ID: 24587635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virtual navigation-guided radiofrequency ablation for recurrent hepatocellular carcinoma invisible on ultrasound after hepatic resection.
    Zhao QY; Xie LT; Chen SC; Xu X; Jiang TA; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):532-540. PubMed ID: 33020034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of Small Hepatocellular Carcinoma (≤2 cm) in the Caudate Lobe with Sequential Transcatheter Arterial Chemoembolization and Radiofrequency Ablation.
    Hyun D; Cho SK; Shin SW; Rhim H; Koh KC; Paik SW
    Cardiovasc Intervent Radiol; 2016 Jul; 39(7):1015-22. PubMed ID: 26975761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.
    Song MJ; Bae SH; Lee JS; Lee SW; Song DS; You CR; Choi JY; Yoon SK
    Korean J Intern Med; 2016 Mar; 31(2):242-52. PubMed ID: 26874512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transarterial chemoembolization using drug eluting beads and subsequent percutaneous MR-guided radiofrequency ablation in the therapy of intermediate sized hepatocellular carcinoma.
    Hoffmann R; Rempp H; Syha R; Ketelsen D; Pereira PL; Claussen CD; Clasen S
    Eur J Radiol; 2014 Oct; 83(10):1793-8. PubMed ID: 25052871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.